Vitiligo and leukoderma in children

Clinics in Dermatology

Volumn 21, Issue 4, 2003, Pages 283-295

  Herane, Maria Isabel ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIPOTRIOL; CATALASE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; KHELLIN; LEVAMISOLE; METHISOPRINOL; METHOXSALEN; PHENYLALANINE; PSORALEN; STEROID; VITAMIN B COMPLEX;

AMELANOTIC NEVUS; CHILDHOOD DISEASE; CLINICAL FEATURE; CYTOLOGY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; ERYTHEMA STREPTOGENES; EYE INFLAMMATION; EYE TOXICITY; GENE MUTATION; GUTTATA HYPOMELANOSIS; HALO NEVI; HISTOPATHOLOGY; HUMAN; HYPOMELANOSIS; HYPOMELANOSIS OF ITO; HYPOPIGMENTATION; INCIDENCE; LEPROSY; LEUKODERMA; LICHEN SCLEROSUS ET ATROPHICUS; LUPUS ERYTHEMATOSUS; MELANOCYTE; MELANOGENESIS; MYCOSIS FUNGOIDES; NEVUS; ONSET AGE; PATHOGENESIS; PHOTOTHERAPY; PIEBALDISM; PIGMENT CELL; PITYRIASIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PUVA; REVIEW; SARCOIDOSIS; SCALP; SCLERODERMA; SIDE EFFECT; SKIN CANCER; SKIN DEFECT; SURGICAL TECHNIQUE; TINEA VERSICOLOR; TUBEROUS SCLEROSIS; ULTRAVIOLET B RADIATION; UVEITIS; VITILIGO; WAARDENBURG SYNDROME;

EID: 0142249270     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(03)00048-8     Document Type: Article

References (93)

1. Bolognia J.L., Pawelek J.M. Biology of hypopigmentation. J Am Acad Dermatol. 19:1988;217-255.
2. Boissy R.E. The melanocyte its structure, function and subpopulations in skin, eyes and hair . Dermatol Clin. 6:1988;161-167.
3. Pinto F.J., Bolognia J.L. Disorders of hypopigmentation in children. Pediatr Clin North Am. 38:1991;991-1017.
4. Lamerson C., Nordlund J.J. Vitiligo. Harper J., Orange A., Prose N. Textbook of pediatric dermatology 2000. 2000;880-889 Blackwell Science Ltd, London.
5. Lopez P., Oroz J., Silva S. Vitiligo infantil estudio descriptivo . Rev Chil Dermatol. 18:2002;61-66.
6. Krysicka C. Childhood vitiligo. Cutis. 51:1993;25-28.
7. Grimes P., Billings M. Childhood vitiligo clinical spectrum and therapeutic approaches . Hann S.K., Nordlund J.J. Vitiligo: a monograph on the basic and clinical science. 2000;61-75 Blackwell Science Ltd, Oxford.
8. Haider R.M., Grimes P.E., Corvan J. Childhood vitiligo. J Am Acad Dermatol. 16:1987;948-954.
9. Majunder P., Dar S., Li C. A genetical model for vitiligo. Am J Hum Genet. 43:1988;119-125.
10. Majunder P., Nordlund J., Nath S. Pattern of familial aggregation of vitiligo. Arch Dermatol. 129:1993;994-998.
11. Hafez M., Sharaf L., Abdel-Nabi S. The genetics of vitiligo. Acta Derm Venereol (Stockh). 63:1983;249-251.
12. Majunder P.P. Genetics and prevalence of vitiligo vulgaris. Hann S.K., Nordlund J.J. Vitiligo a monograph on the basic and clinical science . 2000;18-20 Blackwell Science Ltd, Oxford.
13. Zamani M., Spaepen M., Sghar S.S., et al. Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol. 145:2001;90-94.
14. Fuente-Fernandez R. Mutation in GTP-cyclohydrolase I gene and vitiligo. Lancet. 350:1997;640.
15. Albert D.M., Nordlund J.J., Lerner A.B. Ocular abnormalities occurring with vitiligo. Ophthalmology. 86:1979;1145-1160.
16. Naughton G.K., Reggiardo D., Bystryn J. Correlation between vitiligo antibodies and extent of depigmentation. J Am Acad Dermatol. 15:1986;978-981.
17. Bystryn J.C., Naughton G.K. The significance of vitiligo antibodies. J Dermatol. 12:1985;1-9.
18. Bystryn J.C. Serum antibodies in vitiligo patients. Clin Dermatol. 7:1989;136-145.
19. Cui J., Bystryn J.C. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Arch Dermatol. 131:1995;314-318.
20. Bystryn J.C. Theories on the pathogenesis of depigmentation immune hypothesis . Hann S.K., Nordlund J.J. Vitiligo a monograph on the basic and clinical science . 2000;129-136 Blackwell Science Ltd, Oxford.
21. Hann S.K., Chun W.H. Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo. Hann S.K., Nordlund J.J. Vitiligo. A monograph on the basic and clinical science. 2000;137-141 Blackwell Science Ltd, Oxford.
22. Orecchia G.E. Neural pathogenesis. Hann S.K., Nordlund J.J. Vitiligo a monograph on the basic and clinical science . 2000;142-150 Blackwell Science Ltd, Oxford.
23. Schwartz R.A., Trotter M.G. Generalized vitiligo with erythroderma. Dermatologica. 167:1983;42-46.
24. Hann S.K., Lee H.J. Segmental vitiligo clinical findings in 208 patients . J Am Acad Dermatol. 35:1996;671-674.
25. Hann S.K. Clinical features of segmental vitiligo. Hann S.K., Nordlund J.J. Vitiligo a monograph on the basic and clinical science . 2000;49-60 Blackwell Science Ltd, Oxford.
26. Kovacs S. Vitiligo. J Am Acad Dermatol. 38:1998;647-666.
27. Hann S.K., Nordlund J.J. Clinical features of generalized vitiligo. Hann S.K., Nordlund J.J. Vitiligo: a monograph on the basic and clinical science . 2000;35-48 Blackwell Science Ltd, Oxford.
28. Grimes P.E. Therapies for vitiligo. Milliken L.E. Drug therapy in dermatology. 2000;339-356 Marcel Dekker Inc, New York.
29. Grimes P.E., Billips M. Childhood vitiligo clinical spectrum and therapeutic approaches . Hann S.K., Nordlund J.J. Vitiligo a monograph on the basic and clinical science . 2000;61-69 Blackwell Science Ltd, Oxford.
30. Schallreuter K.U., Lemke R., Brandt O., et al. Vitiligo and other diseases coexistence or true association? Hamburg Study on 321 patients. Dermatology. 188:1994;269-275.
31. Koga M., Tango T. Clinical features and course of type A and type B vitiligo. Br J Dermatol. 118:1988;223-228.
32. Jaisanker T.J., Baruah M.C., Garg B.R. Vitiligo in children. Int J Dermatol. 31:1992;621-623.
33. Ozdirim G., Renda Y., Baytok V. Vogt-Koyanagi-Harada syndrome in siblings (with a brief review of the literature). Eur J Pediatr. 135:1980;217-219.
34. Weber S.W., Kazdan J.J. The Vogt-Koyanagi-Harada syndrome in children. J Pediatr Ophthalmol. 14:1977;96-99.
35. Moortly R.S., Inamata H., Rao N.A. Vogt-Koyanagi-Harada syndrome (review). Surv Ophthalmol. 39:1995;265-292.
36. Snyder D.A., Tessler H.H. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 90:1980;69-75.
37. Mills M.D., Albert D.M. Ocular and otic findings in vitiligo. Hann S.K., Nordlund J.J. Vitiligo a monograph on the basic and clinical science . 2000;81-96 Blackwell Science Ltd, Oxford.
38. Tsurata D., Hamada T., Teramae H., et al. Inflammatory vitiligo in Vogt-Koyanagi-Harada disease. J Am Acad Dermatol. 44:2001;129-131.
39. Wagoner M.D., Albert D.M., Lerner A.B., et al. New observations on vitiligo and ocular disease. Am J Ophthalmol. 96:1983;16-26.
40. Nordlund J.J., Hann S.K. The association of vitiligo with disorders of other organ systems. Hann S.K., Nordlund J.J. Vitiligo a monograph on the basic and clinical science . 2000;89-96 Blackwell Science Ltd. Oxford.
41. Boisseau-Garsaud A.M., Vezon G., Helenon R., et al. High prevalence of vitiligo in lepromatous leprosy. Int J Dermatol. 39:2000;837-839.
42. Terunuma A., Wataba A., Kato T., Tagami H. Coexistence of vitiligo and sarcoidosis in a patient with circulating antibodies. Int J Dermatol. 39:2000;551-553.
43. Barnadas M.A., Rodríguez-Arias J.M., Alomar A. Subcutaneous sarcoidosis associated with vitiligo pernicious anaemia and autoimmune thyroiditis . Clin Exp Dermatol. 25:2000;55-56.
44. Harman M., Akdeniz S., Cetin H., Tuzcu A. Acanthosis nigricans with vitiligo and insulin resistance. Br J Dermatol. 143:2000;892-918.
45. Nordlund J.J., Majunder P.P. Recent investigations on vitiligo vulgaris. Dermatol Clin. 15:1997;69-78.
46. Porter J. The psychological effects of vitiligo response to impaired appearance . Hann S.K., Nordlund J.J. Vitiligo a monograph on the basic and clinical science . 2000;97-100 Blackwell Science Ltd, Oxford.
47. Porter J., Beuf A., Lerner A., Nordlund J.J. The effect of vitiligo on sexual relationships. J Am Acad Dermatol. 22:1990;221-222.
48. Porter J., Beuf A., Lerner A., Nordlund J.J. The psychological effects of vitiligo a comparison of vitiligo patients with normal controls, with psoriasis patients and with patients with other pigmentary disorders . J Am Acad Dermatol. 15:(pt I):1986;220-225.
49. Sheth P.B. Differential diagnosis of vitiligo vulgaris. Hann S.K., Nordlund J.J. Vitiligo a monograph on the basic and clinical science . 2000;101-120 Blackwell Science Ltd, Oxford.
50. Mitchell I.C., Sweatman M.C., Rustin M.H.A., Wilson R. Ulcerative and hypopigmented sarcoidosis. J Am Acad Dermatol. 15:1986;1062-1065.
51. Powell J., Wojnarowska F. Childhood vulvar lichen sclerosus an increasingly common problem . J Am Acad Dermatol. 44:2001;803-806.
52. Osborne G.E.N., Francis N.D., Bunker C.B. Synchronous onset of penile lichen sclerosus and vitiligo. Br J Dermatol. 143:2000;218-219.
53. Wells B.T., Whyte H.J., Kierland R.R. Pityriasis alba a ten year survey and review of the literature . Arch Dermatol. 82:1960;183-189.
54. Clayton I.M. Superficial fungal infections. Harper J., Oranje A., Prose N. Textbook of pediatric dermatology. 2000;447-472 Blackwell Science Ltd, London.
55. Lai A., Fat R.F.M. Leprosy. Harper J., Oranje A., Prose N. Textbook of pediatric dermatology. 2000;535-546 Blackwell Science Ltd, London.
56. Mathias C.G.T., Maibach H.I., Conant M.A. Perioral leukoderma simulating vitiligo from use of a toothpaste containing cinnamic aldehyde. Arch Dermatol. 116:1980;1172-1173.
57. Grimes P.E. Psoralen photochemotherapy for vitiligo. Clin Dermatol. 15:1997;921-926.
58. Schulpi C.H., Antoniu C., Michas T., Starigos J. Phenylalanine plus ultraviolet light preliminary reports of a promising treatment for childhood vitiligo . Pediatr Dermatol. 6:1989;332-335.
59. Morelli J.G. Vitiligo in children treatment options . Dermatol Ther. 2:1997;93-97.
60. Halder R., Battle E.F., Smith E.M. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Arch Dermatol. 131:1995;734-735.
61. Yalcin B., Sahin S., Bukulmez G., et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone a preliminary study . J Am Acad Dermatol. 44:2001;634-637.
62. Westerhof W., Nievweboer-Krobotova L. Treatment of vitiligo with UVB radiation vs. topical psoralen plus UVA. Arch Dermatol. 133:1997;1525-1528.
63. Scherschun L., Kim J.J., Lim H.W. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol. 44:2001;999-1003.
64. Schallreuter K.U., Wood J.M., Lemke K.R., et al. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short term UVB exposure a case study on 33 patients . Dermatology. 190:1995;223-229.
65. Ortel B., Tanew A., Honigsman H. Treatment of vitiligo with khellin and ultraviolet light. J Am Acad Dermatol. 18:1988;693-701.
66. Suite M., Quamina D.B. Treatment of vitiligo with topical melagenina, a human placental extract. J Am Acad Dermatol. 24:1991;1018-1019.
67. Comings D.E., Odland G.F. Partial albinism. JAMA. 195:1966;519-523.
68. Ortonne J.P. Piebaldism, Waardenburg's syndrome, and related disorders neural crest depigmentation syndromes? Dermatol Clin. 66:1988;205-216.
69. Spritz A.A. Molecular basis of human piebaldism. J Invest Dermatol. 103:1994;137-140.
70. Jimbow K., Fitzpatrick T.B., Szabo G., Hori Y. Congenital circumscribed hypomelanosis a characterization based on electron microscopy study of tuberous sclerosis, nevus depigmentosus and piebaldism . J Invest Dermatol. 64:1975;50-62.
71. Ruiz-Maldonado R. Diseases of pigment change. Ruiz-Maldonado R., Parish L., Beare J. Textbook of pediatric dermatology. 1989;243-262 Grune and Stratton, Philadelphia.
72. Bolognia J.L. Disorders of hypopigmentation and hyperpigmentation. Harper J., Oranje A., Prose N. Textbook of pediatric dermatology. 2000;837-879 Blackwell Science Ltd, London.
73. Falabella R. Repigmentation of leukoderma by minigrafts of normally pigmented skin. J Dermatol Surg Oncol. 4:1978;916-919.
74. Herane M.I., Abarca J. Síndrome de Waardenburg tipo II a propósito de dos casos clínicos . Dermatol (Chile). 10:1994;267-270.
75. Park S., Albert D.M., Bolognia J.L. Ocular manifestations of pigmentary disorders. Dermatol Clin. 10:1992;609-622.
76. Ortonne J.P., Mosher D.B., Fitzpatrick T.B. Skin colour and the melanin pigmentary system genetic and congenital disorders . Ortonne J.P., Mosher D.B., Fitzpatrick T.B. Vitiligo and other hypomelanosis of hair and skin. 1983;1-35 Plenum, New York., 129-132.
77. Webb D.W., Osborne J.P. New research in tuberous sclerosis. BMJ. 304:1992;1647-1648.
78. Zvulonov A., Esterly N. Neurocutaneous syndromes associated with pigmentary skin lesions. J Am Acad Dermatol. 32:1995;915-935.
79. Gomez M.R. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann NY Acad Sci. 615:1991;1-7.
80. Osborne J.P. Diagnosis of tuberous sclerosis. Arch Dis Child. 63:1988;1423-1425.
81. Coupe R.L. Unilateral systematized achromic naevus. Dermatologica. 134:1976;19-35.
82. Alper J.C., Holmes L.B. The incidence and significance of birthmarks in a cohort of 4641 newborns. Pediatr Dermatol. 1:1983;58-68.
83. Lee H.S., Chun Y.S., Hann S.K. Nevus depigmentosus clinical features and histopathologic characteristics in 67 patients . J Am Acad Dermatol. 40:1999;21-26.
84. Dawn G., Dhar S., Handa S., Kanwar A.J. Nevus depigmentosus associated with hemihypertrophy of the limbs. Pediatr Dermatol. 12:1995;286-287.
85. Sugarman G.I., Reed W.B. Two unusual neurocutaneous disorders with facial cutaneous signs. Arch Neurol. 21:1969;242-247.
86. Dahr S., Kanwar A.J., Kaur S. Nevus depigmentation in India: experience with 50 patients. Pediatr Dermotol. 1993;299-300.
87. Nehal K.S., De Benito R., Orlow S.J. Analysis of 54 cases of hypopigmentation along the lines of Blaschko. Arch Dermatol. 132:1996;1167-1170.
88. Gauthier Y., Surleve-Bazeilla J.E. Autologous grafting with non cultured melanocytes a simplified method for treatment of depigmented lesions . J Am Acad Dermatol. 26:1992;191-194.
89. Ruiz-Maldonado R., Toussaint S., Tamayo L., et al. Hypomelanosis of Ito diagnostic criteria and report of 41 cases . Pediatr Dermatol. 9:1992;1-10.
90. Glover M.T., Brett E.M., Atherton D.J. Hypomelanosis of Ito spectrum of the disease . J Pediatr. 115:1989;75-80.
91. Griebel V., Krageloh-Mann I., Michaelis R. Hypomelanosis of Ito report of four cases and survey of the literature . Neuropediatrics. 20:1989;234-237.
92. Buzas J.W., Sina B., Burnett J.W. Hypomelanosis of Ito report of a case and review of the literature . J Am Acad Dermatol. 4:1981;195-204.
93. Donnai D., Read A.P., McKeown C., Andrews T. Hypomelanosis of Ito a manifestation of mosaicism or chimerism . J Med Genet. 25:1988;809-818.